Patent directory · USPTO A61K / A61P
Patents matching “Valo Early Discovery, Inc.”
15 pharma patents match "Valo Early Discovery, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 15 pharmaceutical patents matching "Valo Early Discovery, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10988450
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted -
US 10988441
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
granted -
US 10981915
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10934299
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
granted -
US 10927130
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10913753
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
granted -
US 10906916
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10889592
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
granted -
US 10874649
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
granted -
US 10870645
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
granted -
US 10836741
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10829460
[6,6] fused bicyclic HDAC8 inhibitors
granted -
US 10829461
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted -
US 10829462
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted -
US 10822316
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted